I am excited to tell you about a collaboration we have launched with the FDA to support research to inform the development and evaluation of regulations on the manufacturing, distribution, and marketing of tobacco products. FDA was granted authority to regulate tobacco products by the Family Smoking Prevention and Tobacco Control Act (Tobacco Control Act), which was signed into law in 2009.
FDA has identified 56 research priorities among 7 research areas related to tobacco use and public health. In collaboration with the FDA Center for Tobacco Products (CTP), which oversees implementation of the Tobacco Control Act, we have recently announced several funding opportunities to support scientific research that will inform CTP in carrying out its regulatory authorities. These include a research center program (P50) and ongoing support of a variety of research project grants (R01, R03, and R21). The awards made under these funding announcements will be administered by NIH using designated funds from the FDA CTP for tobacco regulatory science.
This collaboration is a great benefit for both agencies. Several NIH institutes and centers have long supported tobacco-related research. In fiscal year 2011, approximately $362 million was awarded by NIH to support research projects related to tobacco use.
We’re looking forward to helping the FDA CTP in achieving their goals—preventing tobacco use, especially among youth, encouraging current users trying to quit, and decreasing the harms from tobacco product use. We hope researchers are also looking forward to contributing their expertise to this interdisciplinary effort.
For more information about this collaboration, as well as links to research resources and contact information for further questions, check out the “Tobacco Control Regulatory Science: Understanding the Family Smoking Prevention and Tobacco Control Act” website at http://www.cancercontrol.cancer.gov/nih-fda/.
0 Comments